Claudio A. Naranjo

7.4k total citations · 1 hit paper
89 papers, 5.4k citations indexed

About

Claudio A. Naranjo is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Claudio A. Naranjo has authored 89 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 21 papers in Cellular and Molecular Neuroscience and 17 papers in Psychiatry and Mental health. Recurrent topics in Claudio A. Naranjo's work include Neurotransmitter Receptor Influence on Behavior (20 papers), Pharmacovigilance and Adverse Drug Reactions (15 papers) and Treatment of Major Depression (14 papers). Claudio A. Naranjo is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (20 papers), Pharmacovigilance and Adverse Drug Reactions (15 papers) and Treatment of Major Depression (14 papers). Claudio A. Naranjo collaborates with scholars based in Canada, United States and Chile. Claudio A. Naranjo's co-authors include Edward M. Sellers, Kathy Sykora, John T. Sullivan, Joyce Schneiderman, Krista L. Lanctôt, Usoa E. Busto, Usoa Busto, Nathan Herrmann, Martha Sanchez‐Craig and K Kadlec and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Claudio A. Naranjo

88 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Alcohol Withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA‐Ar)

1989 1.4k citations Claudio A. Naranjo, Edward M. Sellers et al. British Journal of Addiction profile →

Peers

Countries citing papers authored by Claudio A. Naranjo

Since Specialization

Citations

This map shows the geographic impact of Claudio A. Naranjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio A. Naranjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio A. Naranjo more than expected).

Fields of papers citing papers by Claudio A. Naranjo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio A. Naranjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio A. Naranjo. The network helps show where Claudio A. Naranjo may publish in the future.

Co-authorship network of co-authors of Claudio A. Naranjo

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio A. Naranjo. A scholar is included among the top collaborators of Claudio A. Naranjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio A. Naranjo. Claudio A. Naranjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacotherapy of Alcoholism in Patients with Co-morbid Psychiatric Disorders 2006 ·Drugs ·Benjamin I. Goldstein, (unknown), Ayal Schaffer, Claudio A. Naranjo	16
2	Pharmacokinetic Applications of Fuzzy Structure Identification and Reasoning 2004 ·Sabanci University ·Kemal Kılıç, Beth Sproule, İ.B. Türkşen, Claudio A. Naranjo	1
3	Pharmacokinetic and Pharmacodynamic Evaluation of the Inhibition of Alprazolam by Citalopram and Fluoxetine 2003 ·Journal of Clinical Psychopharmacology ·Judith Hall, Claudio A. Naranjo, Beth Sproule, Nathan Herrmann	19
4	Fuzzy System Modeling in Pharmacology: An Improved Algorithm 2002 ·SSRN Electronic Journal ·Kemal Kılıç, Beth Sproule, İ.B. Türkşen, Claudio A. Naranjo	3
5	Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease 2002 ·International Journal of Geriatric Psychiatry ·Krista L. Lanctôt, Nathan Herrmann, Robert van Reekum, Goran Eryavec, Claudio A. Naranjo	45
6	Brain Reward System Activity in Major Depression and Comorbid Nicotine Dependence 2002 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), Claudio A. Naranjo, Nathan Herrmann, Martin Zack, Usoa E. Busto	41
7	Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram 2001 ·European Neuropsychopharmacology ·Kim Brøsen, Claudio A. Naranjo	102
8	The Effectiveness of Antidepressants in Elderly Depressed Outpatients 1999 ·The Journal of Clinical Psychiatry ·Nicole Mittmann, Nathan Herrmann, Kenneth I. Shulman, Ivan Silver, Usoa E. Busto, (unknown), Claudio A. Naranjo, Neil H. Shear	10
9	Efficacy and Safety of Neuroleptics in Behavioral Disorders Associated With Dementia 1998 ·The Journal of Clinical Psychiatry ·Krista L. Lanctôt, (unknown), Nicole Mittmann, Barbara A. Liu, Paul Oh, Thomas R. Einarson, Claudio A. Naranjo	98
10	El eneagrama de la sociedad: males del mundo, males del alma 1995 ·Claudio A. Naranjo	2
11	Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events* 1995 ·Clinical Pharmacology & Therapeutics ·Krista L. Lanctôt, Claudio A. Naranjo	66
12	Improving the Diagnosis of Hypersensitivity Reactions Associated with Sulfonamides 1994 ·The Journal of Clinical Pharmacology ·Krista L. Lanctôt, (unknown), Neil H. Shear, Claudio A. Naranjo	16
13	Computer‐Assisted Evaluation of Adverse Events Using a Bayesian Approach 1994 ·The Journal of Clinical Pharmacology ·Krista L. Lanctôt, Claudio A. Naranjo	29
14	Eating disorders and alcohol abuse in women 1992 ·British Journal of Addiction ·David S. Goldbloom, Claudio A. Naranjo, Karen E. Bremner, Lisa K. Hicks	32
15	Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers 1992 ·Clinical Pharmacology & Therapeutics ·Claudio A. Naranjo, Constantine X. Poulos, Karen E. Bremner, Krista L. Lanctôt	88
16	Recent Developments in Computer-Assisted Diagnosis of Putative Adverse Drug Reactions 1991 ·Drug Safety ·Claudio A. Naranjo, Krista L. Lanctôt	10
17	Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers 1990 ·Clinical Pharmacology & Therapeutics ·Claudio A. Naranjo, K Kadlec, (unknown), (unknown), Edward M. Sellers	170
18	Ayahuasca imagery and the therapeutic property of harmala alkaloids. 1987 ·Claudio A. Naranjo	5
19	Nifedipine delays the acquisition of tolerance to ethanol 1987 ·European Journal of Pharmacology ·P.H. Wu, Thomas Pham, Claudio A. Naranjo	50
20	Role of 3,4-Dimethoxyphenethylamine in Schizophrenia 1966 ·Nature ·Alexander T. Shulgin, Thornton Sargent, Claudio A. Naranjo	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact